The festival is backed by engineering firms such as Lockheed Martin as well as biotechs like Life Technologies Corp., Johnson and Johnson, Amgen Inc., Celgene Corp., Illumina Inc., Agilent Technologies Inc

The festival is backed by engineering firms such as Lockheed Martin as well as biotechs like Life Technologies Corp., Johnson and Johnson, Amgen Inc., Celgene Corp., Illumina Inc., Agilent Technologies Inc

Ltd. (Japan) BAN2401 Targets beta amyloid aggregates Alzheimer's disease First patient has been dosed in a clinical trial to determine a safe dose range and changes in Alzheimer's biomarkers (9/7) Dynavax Technologies Corp

Life Technologies Corp., of Carlsbad, California, completed its acquisition of Guilford, Conn.-based Ion Torrent Systems Inc

investors were AgeChem Venture Fund, BDC Venture Capital, GO Capital and Epicentre Technologies Corp

acted as placement agent (9/14) Dyadic International Inc. (PK:DYAI) Private placement of convertible notes N/A $1 Dyadic added $1M to its private placement of $3M, resulting in gross proceeds of $4M (9/8) Dynavax Technologies Corp. (DVAX) At-the-market stock offering 1S $2 Dynavax received $2M initially, with Aspire Capital paying $2 per share

Dynavax Technologies Corp., of Berkeley, Calif., said the data safety monitoring board completed the third of its planned safety assessments and determined that the two ongoing Phase III trials of Heplisav, a vaccine comprising a hepatitis B surface antigen with a Toll-like receptor 9 agonist, may continue without protocol modification

Dynavax Technologies Corp., of Berkeley, Calif., filed a shelf registration statement with the SEC under which it may raise up to $100 million through the future sale of stock or debt securities

Dynavax Technologies Corp

Dynavax Technologies Corp., of Berkeley, Calif., started a Phase Ib trial combining its universal flu vaccine, N8295, with Basel, Switzerland-based Novartis AG's investigational H5N1 avian influenza vaccine

Staff Writer With an eye toward partner discussions, Dynavax Technologies Corp

Technologies Corp. (DVAX) (Lead) 4/13 $1.45 $1.62 $44 +12% Ironwood Pharmaceuticals Inc. (IRWD) (IPO) 2/3 $11.25 $9.27 $216 -18% ZymoGenetics Inc. (ZGEN) 1/7 $6 $5 $96.6 -17% William Blair & Co

Applied Genetic Technologies Corp., of Gainesville, Fla., received a $1 million grant from the FDA's orphan drugs program to fund a Phase II trial of alpha 1 antitrypsin deficiency, a genetic disease known to result in serious lung and/or liver disease

Ondine Biopharma Corp., of Vancouver, British Columbia, completed the sale of a majority interest in Sinuwave Technologies Corp., which was formed by the company as a dedicated vehicle for the development of photodisinfection solutions for the chronic sinusitis market, to a group of private equity investors for an undisclosed cash payment

Investors included AgeChem Venture Fund, BDC Venture Capital, GO Capital and Epicentre Technologies Corp

each unit consists of one common share and one common share purchase warrant (8/10) Idera Pharmaceuticals Inc. (IDRA) Registered direct offering 4U $15 Idera raised $15M in the offering of 4M units of stocks and warrants, priced at $3.71, to certain institutional investors (8/4) IntelGenx Technologies Corp. (Canada; CDNX:IGX) Private placement of units 6.5U C$2.6 ($2.5) IntelGenx raised $2.5M in a private placement offering of 6.5M units priced at C40 cents apiece

Functional Technologies Corp., of Toronto, in cooperation with University of Toronto scientists, reported promising initial results of a yeast-based approach for the treatment of malaria

Dynavax Technologies Corp., of Berkeley, Calif., was awarded a five-year, $17.6 million grant from the National Institute of Allergy and Infectious Diseases to take a systems biology approach to study the differences between individuals who do or do not respond to vaccination against the hepatitis B virus

IntelGenx Technologies Corp., of Saint Laurent, Quebec, raised C$2.6 million (US$2.5 million) in a private placement offering of 6.5 million units priced at C40 cents apiece